GRANITE: Airsupra Effectiveness in the Real World
NCT07141277 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000
Last updated 2026-04-09
Summary
The GRANITE study aims to evaluate the effectiveness of Airsupra versus albuterol in reducing asthma exacerbation risk in a real-world US population.
Conditions
Interventions
- OTHER
-
None (Observational study)
Not applicable since it's an observational study.
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-09
- Primary Completion
- 2026-06-30
- Completion
- 2026-06-30
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)
NCT03528577 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma
NCT07098403 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
NCT07219173 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Step-up in Bronchial Asthma as a New End Point in Asthma Control (SURFE)
NCT05632081 ·Status: RECRUITING
-
Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma
NCT03371459 ·Status: COMPLETED ·Phase: PHASE2
-
A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)
NCT01056159 ·Status: COMPLETED ·Phase: PHASE1
-
Bronchoprovocation Study to Evaluate the Pharmacodynamics of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base
NCT03549897 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma
NCT02127697 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study With GW274150 In Patients With Mild Asthma
NCT00273013 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home
NCT02417961 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing the Efficacy of Bricanyl M2 and Bricanyl M3 at 0.5 and 1.5 mg Dose Levels, to Allow for a Switch From Bricanyl Turbuhaler M2 to Bricanyl Turbuhaler M3
NCT02322788 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Long-Term Extension Study With Dexpramipexole
NCT06388889 ·Status: TERMINATED ·Phase: PHASE3
-
A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma
NCT05593250 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Safety, Pharmacokinetic, and Pharmacodynamic Study of Once Daily Inhaled AZD8630 in Adults With Asthma
NCT06795906 ·Status: COMPLETED ·Phase: PHASE1
-
Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI
NCT00565591 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma
NCT06748053 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Specific Use-Result of Spiriva Respimat® in Asthmatics
NCT03188120 ·Status: COMPLETED
-
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
NCT01424813 ·Status: COMPLETED ·Phase: PHASE3
-
45th Multicenter Airway Research Collaboration
NCT07166939 ·Status: RECRUITING ·Phase: PHASE4
-
Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at Home
NCT02918071 ·Status: COMPLETED ·Phase: PHASE3
-
Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics
NCT00308685 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma
NCT01058863 ·Status: COMPLETED ·Phase: PHASE2
-
A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma
NCT01641692 ·Status: COMPLETED ·Phase: PHASE2
-
Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma
NCT02433834 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma
NCT06245551 ·Status: COMPLETED ·Phase: PHASE3